Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet licensed by the MHRA or EMA, and currently in Phase 2 and Phase 3 clinical trials
doi: 10.1002/oby.23621
In a statement, Lilly confirmed that the treatment delivered significant weight loss, meaningful A1C reductions and improvements in cardiometabolic risk factors at 72 weeks
Incorporating foods like chia seeds, flaxseeds, and whole grains into your diet may help increase GLP-1 levels naturally
COA & Testing (30%) We verify that COAs are: From recognized third-party labs Recent (within the last 6 months) Verifiable on the lab's website Testing for identity, purity, and contamination Reputation (30%) Community feedback from peptide forums, shipping reliability, customer service responsiveness, and business track record
US$ 25.40
US$ 23.04
US$ 23.36
US$ 20.21
US$ 23.50
US$ 25.28
US$ 23.78
US$ 24.66
US$ 29.93
